Alcon (ALC)
Builds surgical eye-care systems, contact lenses, and ocular-health products for global markets.
$65.72
After hours+0.13 (+0.20%)
At close$65.59(+1.11%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,329 | 2,352 | 2,459 | 2,496 | 2,454 | 2,502 | 2,473 | 2,596 | 2,614 | 2,718 | 2,653 | 2,823 |
| Cost of revenue | 1,040 | 1,062 | 1,077 | 1,122 | 1,083 | 1,117 | 1,090 | 1,208 | 1,156 | 1,245 | 1,158 | 1,148 |
| Gross profit | 1,289 | 1,290 | 1,382 | 1,374 | 1,371 | 1,385 | 1,383 | 1,388 | 1,458 | 1,473 | 1,495 | 1,675 |
| 996 | 1,082 | 1,014 | 1,056 | 1,039 | 990 | 915 | 1,141 | 1,126 | 1,160 | 1,085 | 1,664 | |
| Research & development | 201 | 239 | 199 | 220 | 225 | 232 | 222 | 245 | 250 | 273 | 240 | 663 |
| Selling, general & administrative | 798 | 794 | 802 | 837 | 809 | 802 | 813 | 870 | 865 | 901 | 844 | 964 |
| Other expenses | −3 | 49 | 13 | −1 | 5 | −44 | −120 | 26 | 11 | −14 | 0 | 37 |
| Operating income | 293 | 208 | 368 | 318 | 332 | 395 | 468 | 247 | 332 | 313 | 411 | 11 |
| −55 | −40 | −33 | −38 | −40 | −46 | −54 | −48 | −49 | −49 | −176 | −57 | |
| Interest income | 0 | 0 | 12 | 12 | 10 | 38 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 47 | 50 | 45 | 50 | 49 | 48 | 50 | 51 | 51 | 53 | 51 | 53 |
| Other non-operating income | 0 | −7 | 0 | −12 | −9 | 58 | 5 | −3 | −2 | 49 | 125 | 4 |
| Income before tax | 238 | 168 | 335 | 280 | 292 | 349 | 414 | 199 | 283 | 264 | 235 | −46 |
| Income tax expense | 34 | −259 | 87 | 57 | 29 | 65 | 64 | 23 | 46 | 47 | 50 | −46 |
| Net income from continuing operations | 204 | 427 | 248 | 223 | 263 | 284 | 350 | 176 | 237 | 217 | 185 | 0 |
| Net income | 204 | 427 | 248 | 223 | 263 | 284 | 350 | 176 | 237 | 217 | 185 | 0 |
| EPS, basic | $0.41 | $0.87 | $0.50 | $0.45 | $0.53 | $0.57 | $0.71 | $0.36 | $0.48 | $0.44 | $0.38 | $0.00 |
| EPS, diluted | $0.41 | $0.87 | $0.50 | $0.45 | $0.53 | $0.57 | $0.70 | $0.35 | $0.48 | $0.44 | $0.38 | $0.00 |
| Weighted average shares, basic | 493 | 493 | 494 | 495 | 495 | 494 | 495 | 495 | 493 | 489 | 487 | 487 |
| Weighted average shares, diluted | 496 | 493 | 497 | 497 | 498 | 498 | 498 | 498 | 496 | 492 | 490 | 489 |
| EBITDA | 578 | 544 | 656 | 641 | 629 | 616 | 773 | 612 | 665 | 521 | 565 | 270 |
| Depreciation & amortization | 285 | 329 | 288 | 311 | 288 | 279 | 310 | 362 | 331 | 257 | 278 | 263 |
| EBIT | 293 | 215 | 368 | 330 | 341 | 337 | 463 | 250 | 334 | 264 | 286 | 7 |